Bioventix (BVXP) Competitors GBX 3,300 -130.00 (-3.79%) (As of 12:32 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades BVXP vs. ERGO, SLN, OXB, PRTC, HZD, VRP, ARIX, FARN, AVCT, and 4BBShould you be buying Bioventix stock or one of its competitors? The main competitors of Bioventix include Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), Faron Pharmaceuticals Oy (FARN), Avacta Group (AVCT), and 4basebio (4BB). These companies are all part of the "biotechnology" industry. Bioventix vs. Ergomed Silence Therapeutics Oxford Biomedica PureTech Health Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Arix Bioscience Faron Pharmaceuticals Oy Avacta Group 4basebio Bioventix (LON:BVXP) and Ergomed (LON:ERGO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings. Is BVXP or ERGO more profitable? Bioventix has a net margin of 63.73% compared to Ergomed's net margin of 9.87%. Bioventix's return on equity of 79.14% beat Ergomed's return on equity.Company Net Margins Return on Equity Return on Assets Bioventix63.73% 79.14% 54.07% Ergomed 9.87%18.08%10.16% Does the media prefer BVXP or ERGO? In the previous week, Bioventix had 2 more articles in the media than Ergomed. MarketBeat recorded 2 mentions for Bioventix and 0 mentions for Ergomed. Bioventix's average media sentiment score of 0.37 beat Ergomed's score of 0.00 indicating that Bioventix is being referred to more favorably in the media. Company Overall Sentiment Bioventix Neutral Ergomed Neutral Which has more volatility & risk, BVXP or ERGO? Bioventix has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Ergomed has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Do insiders and institutionals believe in BVXP or ERGO? 62.3% of Bioventix shares are held by institutional investors. Comparatively, 71.1% of Ergomed shares are held by institutional investors. 8.0% of Bioventix shares are held by insiders. Comparatively, 18.2% of Ergomed shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer BVXP or ERGO? Ergomed received 150 more outperform votes than Bioventix when rated by MarketBeat users. Likewise, 75.63% of users gave Ergomed an outperform vote while only 52.87% of users gave Bioventix an outperform vote. CompanyUnderperformOutperformBioventixOutperform Votes9252.87% Underperform Votes8247.13% ErgomedOutperform Votes24275.63% Underperform Votes7824.38% Which has preferable valuation & earnings, BVXP or ERGO? Ergomed has higher revenue and earnings than Bioventix. Bioventix is trading at a lower price-to-earnings ratio than Ergomed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioventix£13.60M12.52£8.67M£1.632,001.53Ergomed£152.09M4.61£15M£0.294,641.38 SummaryErgomed beats Bioventix on 8 of the 15 factors compared between the two stocks. Ad Porter & CompanyU.S. Government: “this could save civilization.”Experts indicate that ChatGPT alone consumes up to 17,000 times more electricity than the average U.S. household uses in a single day. And with companies like Google and Microsoft implementing AI into everything we do, that energy consumption is only going to exponentially increase. Thing is, outside of a small group of elite investors, nobody has connected the dots on how this military contractor could be the most important company in the AI boom.To get all the details, go here now. Get Bioventix News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BVXP vs. The Competition Export to ExcelMetricBioventixBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£170.30M£202.77M£5.14B£1.40BDividend Yield3.95%3.54%4.81%11.74%P/E Ratio2,001.53317.19135.301,558.04Price / Sales12.5215,353.351,186.56311,012.94Price / Cash30.8911.6740.4232.94Price / Book14.907.264.872.85Net Income£8.67M-£18.52M£118.61M£152.80M7 Day Performance-6.79%185.89%15.32%18.96%1 Month Performance-13.00%134.13%15.26%18.69%1 Year Performance-22.93%114.29%34.42%23.73% Bioventix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BVXPBioventixN/AGBX 3,300-3.8%N/A-16.3%£172.26M£13.60M2,001.5312ERGOErgomedN/AN/AN/AN/A£701.00M£152.09M4,641.386SLNSilence TherapeuticsN/AGBX 535-0.9%N/AN/A£480.35M£11.35M-11.01100Positive NewsHigh Trading VolumeOXBOxford Biomedica0.4747 of 5 starsGBX 423.50flatGBX 433.33+2.3%+112.6%£446.20M£97.28M-295.83891PRTCPureTech Health2.3772 of 5 starsGBX 170+4.4%GBX 455+167.6%+9.0%£407.01M£3.33M-739.13300Analyst ForecastNews CoverageHigh Trading VolumeHZDHorizon Discovery Group plc (HZD.L)N/AGBX 184.50flatN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/A+0.0%£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/A+20.3%£183.73M£14.16M1,290.919FARNFaron Pharmaceuticals OyN/AN/AN/A-49.3%£175.45M£-725,000.00-524.0634AVCTAvacta GroupN/AGBX 45.75+6.4%N/A-59.1%£163.92M£22.62M-513.33120Negative News4BB4basebioN/AGBX 1,210+2.1%N/A+86.2%£155.00M£311,000.00-1,551.28101News CoveragePositive News Related Companies and Tools Related Companies Ergomed Competitors Silence Therapeutics Competitors Oxford Biomedica Competitors PureTech Health Competitors Horizon Discovery Group plc (HZD.L) Competitors Verona Pharma plc (VRP.L) Competitors Arix Bioscience Competitors Faron Pharmaceuticals Oy Competitors Avacta Group Competitors 4basebio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:BVXP) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
